These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6160106)

  • 61. In vitro and in vivo antibacterial activities of FK037, a novel parenteral broad-spectrum cephalosporin.
    Fu KP; Foleno BD; Lafredo SC; LoCoco JM; Isaacson DM
    Antimicrob Agents Chemother; 1993 Feb; 37(2):301-7. PubMed ID: 8452361
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
    Mine Y; Watanabe Y; Sakamoto H; Hatano K; Wakai Y; Kamimura T; Tawara S; Matsumoto S; Matsumoto F; Kuwahara S
    J Antibiot (Tokyo); 1993 Jan; 46(1):88-98. PubMed ID: 8436563
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Humanized tissue pharmacodynamics of cefazolin against commonly isolated pathogens in skin and skin structure infections.
    Jain JG; Housman ST; Nicolau DP
    J Antimicrob Chemother; 2014 Sep; 69(9):2443-7. PubMed ID: 24827890
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bactericidal effect of graphene oxide/Cu/Ag nanoderivatives against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus.
    JankauskaitĿ V; VitkauskienĿ A; Lazauskas A; Baltrusaitis J; ProsyĿevas I; AndruleviĿius M
    Int J Pharm; 2016 Sep; 511(1):90-97. PubMed ID: 27370911
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2004)].
    Goto H; Takeda H; Kawai S; Watanabe T; Okazaki M; Shimada K; Nakano K; Yokouchi H; Ikemoto H; Mori T; Igari J; Oguri T; Yamamoto M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Gejyo F; Okada M; Aoki N; Kitamura N; Suzuki Y; Karasawa Y; Kudo K; Kobayashi N; Tanaka T; Sumitomo M; Matsushima T; Oka M; Niki Y; Suga M; Tosaka M; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Nasu M; Hiramatsu K; Oikawa S
    Jpn J Antibiot; 2006 Oct; 59(5):323-54. PubMed ID: 17180803
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In-vitro activity of pefloxacin compared to other antibiotics.
    Yourassowsky E; Van der Linden MP; Crokaert F; Glupczynski Y
    J Antimicrob Chemother; 1986 Apr; 17 Suppl B():19-28. PubMed ID: 3086279
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Gram-negative infections in cancer. Study of empiric therapy comparing carbenicillin-cephalothin with and without gentamicin.
    Klastersky J; Henri A; Hensgens C; Daneau D
    JAMA; 1974 Jan; 227(1):45-8. PubMed ID: 4202683
    [No Abstract]   [Full Text] [Related]  

  • 68. Coriander essential oil and linalool - interactions with antibiotics against Gram-positive and Gram-negative bacteria.
    Aelenei P; Rimbu CM; Guguianu E; Dimitriu G; Aprotosoaie AC; Brebu M; Horhogea CE; Miron A
    Lett Appl Microbiol; 2019 Feb; 68(2):156-164. PubMed ID: 30471142
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effect of sulfur hexafluoride gas on antibacterial activity of antibiotics in vitro against agents causing endophthalmitis.
    Yanyali A; Cetin S; Talu H; Vahaboglu H
    Ophthalmologica; 2001; 215(6):439-43. PubMed ID: 11741112
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The effect of albumin, globulin, pus and dead bacteria in aerobic and anaerobic conditions on the antibacterial activity of moxifloxacin, trovafloxacin and ciprofloxacin against Streptococcus pneumoniae, Staphylococcus aureus and Escherichia coli.
    Rubinstein E; Diamantstein L; Yoseph G; Gruzman G; Rubinovitch B; Barzilai A; Keller N
    Clin Microbiol Infect; 2000 Dec; 6(12):678-81. PubMed ID: 11284929
    [No Abstract]   [Full Text] [Related]  

  • 71. Enhancement of resistance to bacterial infection in mice by vitamin B2.
    Araki S; Suzuki M; Fujimoto M; Kimura M
    J Vet Med Sci; 1995 Aug; 57(4):599-602. PubMed ID: 8519884
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
    Lagast H; Husson M; Klastersky J
    J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibacterial action of a heat-stable form of L-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom.
    Lee ML; Tan NH; Fung SY; Sekaran SD
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Mar; 153(2):237-42. PubMed ID: 21059402
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Sensitivity of microorganisms isolated from swine to aqueous and proteinic solutions of gentamycin].
    Boiadzhieva A
    Vet Med Nauki; 1978; 15(1):78-83. PubMed ID: 80055
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Spontaneous bacterial peritonitis due to multidrug resistant bacteria: are the current guidelines outdated?
    Fiore M
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):731. PubMed ID: 27111388
    [No Abstract]   [Full Text] [Related]  

  • 76. [Bactericidal kinetics of cefazolin, cefoxitin and amikacin alone and in combination (author's transl)].
    Shah PM; Stille W
    Arzneimittelforschung; 1978; 28(9):1539-41. PubMed ID: 383106
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens.
    Hill HR; Augustine NH; Shigeoka AO
    Am J Med; 1984 Mar; 76(3A):61-6. PubMed ID: 6424458
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.
    Fernandes PB; Chu DT; Bower RR; Jarvis KP; Ramer NR; Shipkowitz N
    Antimicrob Agents Chemother; 1986 Feb; 29(2):201-8. PubMed ID: 3521473
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Susceptibility of bacteria isolated from patients with lower respiratory tract infections to antibiotics (1987)].
    Ikemoto H; Watanabe K; Kosakai N; Hayashi Y; Oguri T; Kondou T; Saitou A; Matsumiya H; Ueda K; Terai T
    Jpn J Antibiot; 1990 Jan; 43(1):147-80. PubMed ID: 2112206
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Comparative studies on activities of antimicrobial agents against causative organisms isolated from urinary tract infections (1989). I. Susceptibility distribution].
    Kumamoto Y; Hirose T; Tanaka N; Hikichi Y; Shigeta S; Shiraiwa Y; Kameoka H; Yoshida H; Ogata M; Tazaki H
    Jpn J Antibiot; 1995 Sep; 48(9):1131-60. PubMed ID: 7474333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.